Afya Limited (AFYA)
After hours:
| Previous close | 19.14 |
| Open | 19.23 |
| Bid | 19.32 x 400 |
| Ask | 19.41 x 200 |
| Day's range | 19.02 - 19.76 |
| 52-week range | 11.42 - 22.48 |
| Volume | |
| Avg. volume | 126,238 |
| Market cap | 1.744B |
| Beta (5Y monthly) | 0.98 |
| PE ratio (TTM) | 23.08 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Afya Limited Announces First-Quarter 2024 Financial Results
NOVA LIMA, Brazil, May 09, 2024--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three-month period ended March 31, 2024 (first quarter 2024). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).
- Business Wire
Afya Limited Announces Entering Into a Share Purchase Agreement for the Acquisition of Unidompedro and Faculdade Dom Luiz
NOVA LIMA, Brazil, May 02, 2024--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and digital health services provider in Brazil, announced today that it has entered into a share purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Unidom Participações S.A. ("Unidompedro" and "Faculdade Dom Luiz"), present in Salvador (BA), Luis Eduardo Magalhães (BA), Barre
- Business Wire
Afya Limited Announces Fourth Quarter and Full-Year 2023 Financial Results
NOVA LIMA, Brazil, March 14, 2024--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and digital health services provider in Brazil, reported today financial and operating results for the fourth quarter and full-year period ended December 31, 2023. Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).
